Sanofi Defends Validity Of Pen Injector Patent Before Patent Board
ALEXANDRIA, Va. — In a June 25 filing with the Patent Trial and Appeal Board, Sanofi-Aventis Deutschland GMBH pointed to the “overwhelming” commercial success of its “LANTUS® SoloSTAR®” pen injector as...To view the full article, register now.
Already a subscriber? Click here to view full article